BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Jan. 29, 2020

View Archived Issues
finance-dollar-growth.png

IDbyDNA snags $20M in series B funding

IDbyDNA Inc., a San Francisco-based metagenomics technology company, scooped up $20 million in series B financing in a round led by Artis Ventures. Genesys Capital and others participated in the round. The company plans to use the money to accelerate uptake of its Explify software platform. Read More
Stock surge

Stryker sees strength in robotics as Mako delivers good news

Stryker Corp., of Kalamazoo, Mich., saw strength in the fourth quarter, with Mako experiencing good uptake in total knee arthroplasty. Katherine Owen, Stryker’s vice president of strategy & investor relations, said Mako demand was driven by the benefits of its robotic technology, multiple applications and the ability to do cementless knee. Read More
1-29-verily-study-watch.png

Verily gets second Study Watch FDA clearance as it digs into Irhythm AF collaboration

Diabetes is the first med-tech sphere that is coalescing for Verily Life Sciences LLC, but cardiology could be next. The South San Francisco-based business that’s part of Google parent Alphabet Inc. has received a second FDA clearance for its Verily Study Watch as an irregular pulse monitor. After a 2017 debut, it was first cleared by the agency about a year ago for use to take an on-demand electrocardiogram (ECG). Read More
latin-south-america-globe.png

Med-tech sector crashes in Venezuela

BOGOTA, Colombia – Venezuela’s med-tech sector has been virtually decimated by the ongoing crisis, which has not only displaced millions of people but also destroyed the country’s economy over the past four years. Read More
dollar-idea-lightbulb.png

Genomictree’s U.S. branch attracts $30.8M for cancer diagnostics kits clinical study

HONG KONG – South Korea’s Genomictree Co. Ltd. has said its U.S. branch, Promis Diagnostics Inc., based in Pasadena, Calif., gained $30.8 million in funds this month. The Daejeon-based company has secured $40.8 million for its U.S. subsidiary since founding it in August 2019. Read More
Coronavirus.png

HHS Secretary: No emergency here … yet

Despite pressure from several lawmakers to declare the new coronavirus a U.S. public health emergency, Health and Human Services (HHS) Secretary Alex Azar said such a declaration isn’t needed, at least not yet. Read More
Coronavirus-Wuhan-virus-alert-keyboard.png

NCoV’s spread is rapid, but so are communications, countermeasures

LONDON – It has gone from “pneumonia of unknown cause” affecting 44 patients in Wuhan, China, on Jan. 5, 2020, to spark a global health alert, with the World Health Organization (WHO) now looking likely to declare the outbreak of the novel coronavirus, 2019-nCoV, a public health emergency of international concern (PHEIC) less than four weeks later. Read More

BioWorld MedTech tracks the Wuhan coronavirus outbreak

See BioWorld’s ongoing coverage of the 2019-nCoV coronavirus outbreak. Read More

Appointments and advancements for Jan. 29, 2020

New hires and promotions in the med-tech industry, including: Tela Bio Read More

Financings for Jan. 29, 2020

Med-tech firms raising money in public or private financings, including: Butterfly Medical, Cerus, CHF Solutions, Itamar Medical, Synedgen Read More

In the clinic for Jan. 29, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bluestar Genomics, Polarean Read More

Other news to note for Jan. 29, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biodesix, Bright Machines, Current Health, Diagnostics for the Real World, Physiq, Sai Life Sciences, Sanuwave Health, Sequana Medical, Scorpio-V, Streck, Valdovations Read More

Regulatory actions for Jan. 29, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents Read More

Regulatory front for Jan. 29, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies. Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 29, 2020

Keeping you up to date on recent developments in orthopedics, including: Tiny salamander's huge genome may harbor the secrets of regeneration; New injection technique may boost spinal cord injury repair efforts; ACL tears cause harmful changes in brain structure Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing